UY26870A1 - Antibióticos macrólidos - Google Patents

Antibióticos macrólidos

Info

Publication number
UY26870A1
UY26870A1 UY26870A UY26870A UY26870A1 UY 26870 A1 UY26870 A1 UY 26870A1 UY 26870 A UY26870 A UY 26870A UY 26870 A UY26870 A UY 26870A UY 26870 A1 UY26870 A1 UY 26870A1
Authority
UY
Uruguay
Prior art keywords
macrolid antibiotics
macrolid
antibiotics
macrolic
antibiotic
Prior art date
Application number
UY26870A
Other languages
English (en)
Inventor
Yan Chen
Wei Guo Su
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of UY26870A1 publication Critical patent/UY26870A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Un antibiótico macrólico de fórmula (I) en la que las variables se definen como se ha descrito en la presente memoria.
UY26870A 2000-08-07 2001-08-07 Antibióticos macrólidos UY26870A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22359100P 2000-08-07 2000-08-07

Publications (1)

Publication Number Publication Date
UY26870A1 true UY26870A1 (es) 2002-03-22

Family

ID=22837162

Family Applications (1)

Application Number Title Priority Date Filing Date
UY26870A UY26870A1 (es) 2000-08-07 2001-08-07 Antibióticos macrólidos

Country Status (17)

Country Link
US (2) US20020115621A1 (es)
EP (1) EP1307468A1 (es)
JP (1) JP2004505987A (es)
AP (1) AP2001002236A0 (es)
AR (1) AR034695A1 (es)
AU (1) AU2001272719A1 (es)
BR (1) BR0112863A (es)
CA (1) CA2419044A1 (es)
DO (1) DOP2001000228A (es)
GT (1) GT200100159A (es)
HN (1) HN2001000176A (es)
MX (1) MXPA03001148A (es)
PA (1) PA8524501A1 (es)
PE (1) PE20020468A1 (es)
TN (1) TNSN01121A1 (es)
UY (1) UY26870A1 (es)
WO (1) WO2002012260A1 (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP2001002302A0 (en) 1999-05-24 2001-10-25 Pfizer Prod Inc 13-Methyl erythromycin derivatives.
DE60138876D1 (de) * 2000-03-28 2009-07-16 Sandoz Ag Geschmackmaskierte granulierte teilchen
WO2003102010A1 (en) * 2002-05-31 2003-12-11 Janssen Pharmaceutica N.V. 3-descladinosyl-6-o-carbamoyl and 6-o-carbonoyl macrolide antibacterial agents
HRP20020885B1 (en) 2002-11-11 2007-05-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. SUBSTITUTED 9a-N-{N'-[4-(SULFONYL)PHENYLCARBAMOYL]}DERIVATIVES 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERITHROMYCIN A AND 5-O-DESOZAMINYL-9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERITHRONOLIDE A
ES2552682T3 (es) 2003-03-10 2015-12-01 Merck Sharp & Dohme Corp. Agentes antibacterianos novedosos
GB0310981D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
HRP20030381B1 (en) * 2003-05-14 2007-05-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 3-DECLADINOZYL 9a-N-CARBAMOYL AND 9a-N-THIOCARBAMOYL DERIVATIVES 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERYTHROMICYNE A
WO2005030227A1 (en) 2003-09-23 2005-04-07 Enanta Pharmaceuticals, Inc. 9a, 11-3C-BICYCLIC 9a-AZALIDE DERIVATIVES
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
JP2008508322A (ja) * 2004-07-28 2008-03-21 ランバクシー ラボラトリーズ リミテッド 抗菌剤としてのケトライド誘導体
US7402568B2 (en) 2004-09-29 2008-07-22 Enanta Pharmaceuticals, Inc. Bicyclic 9a-azalide derivatives
WO2006046112A2 (en) * 2004-10-25 2006-05-04 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
UA85937C2 (uk) 2004-12-21 2009-03-10 Пфайзер Продактс Інк. Макроліди
US7271155B2 (en) 2005-01-07 2007-09-18 Enanta Pharmaceuticals, Inc. 9A, 11-2C-bicyclic 9a-azalide derivatives
ES2317527T3 (es) 2005-01-13 2009-04-16 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Decladinosil-macrolidos que presentan actividad anti-inflamatoria.
US20090130225A1 (en) * 2005-11-23 2009-05-21 Anjan Chakrabarti Macrolides derivatives as antibacterial agents
WO2007060518A2 (en) * 2005-11-23 2007-05-31 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
US20070281894A1 (en) * 2006-06-05 2007-12-06 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted erythromycin analogs
EP2214484A4 (en) 2007-10-25 2013-01-02 Cempra Pharmaceuticals Inc PROCESS FOR PREPARING ANTIBACTERIAL MAKROLIDE AGENTS
EP2358379B1 (en) * 2008-10-24 2015-12-16 Cempra Pharmaceuticals, Inc. Biodefenses using triazole-containing macrolides
US9937194B1 (en) * 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
US9480679B2 (en) 2009-09-10 2016-11-01 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and MAC diseases
DK2550286T3 (en) 2010-03-22 2016-02-29 Cempra Pharmaceuticals Inc CRYSTALLINE FORMS OF A MACROLID AND APPLICATIONS THEREOF
EP2571506B1 (en) 2010-05-20 2017-05-10 Cempra Pharmaceuticals, Inc. Processes for preparing macrolides and ketolides and intermediates therefor
EP2613630A4 (en) 2010-09-10 2014-01-15 Cempra Pharmaceuticals Inc FLUOROCETOLIDES FORMING HYDROGEN LINKS TO TREAT DISEASES
KR20140139083A (ko) 2012-03-27 2014-12-04 셈프라 파마슈티컬스, 인크. 마크롤라이드계 항생제를 투여하기 위한 비경구 제제
JP6426696B2 (ja) 2013-03-14 2018-11-21 センプラ ファーマシューティカルズ，インコーポレイテッド 呼吸器疾患の治療のための方法および製剤
EP2968384A4 (en) 2013-03-15 2017-02-15 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US40007A (en) 1863-09-22 Improvement in railroad-car brakes
US61856A (en) 1867-02-05 Enos s
US25937A (en) 1859-11-01 ballou
US156027A (en) 1874-10-20 Improvement in loom-shuttles
US100518A (en) 1870-03-08 Roland s
US61857A (en) 1867-02-05 Improvement in top-drivers or spinners
US3923784A (en) 1973-09-10 1975-12-02 Hoffmann La Roche Erythromycin a derivatives
SI8110592A8 (en) 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
US5141926A (en) * 1990-04-18 1992-08-25 Abbott Laboratories Erythromycin derivatives
US5523399A (en) * 1991-12-27 1996-06-04 Taisho Pharmaceutical Co., Ltd. 5-O-desosaminylerythronolide derivatives
FR2745290B1 (fr) 1996-02-28 1998-04-03 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2748746B1 (fr) 1996-05-14 1998-08-14 Hoechst Marion Roussel Inc Nouveau procede d'isomerisation du radical methyle en 10 de derives de l'erythromycine
US5804565A (en) 1996-09-24 1998-09-08 Taisho Pharmaceutical Co., Ltd. Erythromycin A derivatives
CZ180799A3 (cs) 1996-11-27 1999-09-15 Taisho Pharmaceutical Co., Ltd. Deriváty erythromycinu A
US6162794A (en) 1997-05-09 2000-12-19 Pfizer Inc. Erythromycin derivatives
EP0895999A1 (en) 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics
ZA987689B (en) * 1997-09-02 1999-02-24 Abbott Lab 3-descladinose 6-O substituted erythromycin derivatives
ZA989830B (en) 1997-10-29 1999-05-04 Taisho Pharmaceutical Co Ltd Erythromycin a derivatives
HN1998000159A (es) 1997-10-29 1999-02-09 Monsanto Co Derivados de 9- amino - 3 ceto eritromicina
PA8461401A1 (es) 1997-10-29 2000-05-24 Pfizer Prod Inc Derivados de eritromicina triciclicos
AU9649598A (en) 1997-10-29 1999-05-17 Taisho Pharmaceutical Co., Ltd. Erythromycin a, 11,12-carbamate derivatives
WO1999029709A1 (fr) * 1997-12-11 1999-06-17 Hokuriku Seiyaku Co., Ltd. Derives d'erythromycine
AP1060A (en) 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
WO1999062920A1 (en) 1998-06-03 1999-12-09 Pfizer Products Inc. Tricyclic 3-keto derivatives of 6-o-methylerythromycin
OA11753A (en) 1999-01-27 2005-07-19 Pfizer Prod Inc Ketolide antibiotics.
WO2001010878A1 (fr) 1999-08-06 2001-02-15 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a
WO2001010880A1 (fr) 1999-08-06 2001-02-15 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a
US6498146B1 (en) * 1999-10-28 2002-12-24 Pfizer Inc Erythromycin derivatives
EP1101769A3 (en) 1999-11-18 2001-10-24 Pfizer Products Inc. Nitrogen containing erythromycin derivatives

Also Published As

Publication number Publication date
TNSN01121A1 (fr) 2005-11-10
US20020115621A1 (en) 2002-08-22
PE20020468A1 (es) 2002-06-14
US6849608B2 (en) 2005-02-01
US20040009930A1 (en) 2004-01-15
AU2001272719A1 (en) 2002-02-18
AR034695A1 (es) 2004-03-17
CA2419044A1 (en) 2002-02-14
EP1307468A1 (en) 2003-05-07
GT200100159A (es) 2002-03-22
WO2002012260A1 (en) 2002-02-14
DOP2001000228A (es) 2002-09-30
HN2001000176A (es) 2001-10-08
BR0112863A (pt) 2003-07-01
AP2001002236A0 (en) 2001-09-30
JP2004505987A (ja) 2004-02-26
MXPA03001148A (es) 2003-06-09
PA8524501A1 (es) 2002-08-29

Similar Documents

Publication Publication Date Title
UY26870A1 (es) Antibióticos macrólidos
ATE546109T1 (de) Mehrlumige prothesensysteme
PA8527001A1 (es) Poliarilcarboxamidas utiles como agentes reductores de lipidos
ECSP045245A (es) N-aril-2-oxazolidinona-5-carboxamidas y sus derivados
HN2000000051A (es) Derivados heterociclicos utiles como agentes anticancerosos
HN1999000125A (es) Nuevos derivados sustituidos del pirazol
DE60131138D1 (de) Antibakterielle mittel
SV2001000004A (es) Difenil ureas w-carboxyaril sustituidas, composición farmacéutica que las comprende y su uso como inhibidores de raf quinasa
BR0209918A (pt) Formas cristalinas da azitromicina
ECSP003699A (es) Inhibidores de fab i
HN1999000066A (es) Formulaciones farmaceuticas
PT1287001E (pt) Derivados de tiofeno uteis como agentes anticancerigenos
HN2002000247A (es) Derivados de sulfonamida
ATE469910T1 (de) Azithromycinmonohydrat
DE50112902D1 (de) Hautreinigungsmittel
SV2003000981A (es) Fenil-heterociclil-eteres ref. pcs10973
DE69936052D1 (de) N1 modifizierte glycopeptide
BRPI0417205A (pt) composições farmacêuticas
HN1999000008A (es) gen de streptomices
SV2002000582A (es) Antibioticos de macrolida ref.pc11020ashj/bb antibioticos de macrolida ref.pc11020ashj/bb
ECSP034861A (es) Formas cristalinas de azitromicina
ES2421598T3 (es) Composición glucopeptídica con actividad antibiótica mejorada
AR030750A1 (es) 1-amino-alquilciclohexanos como agentes tripanocidas
UA50030A (uk) Комплексне добриво
HN2000000007A (es) Ureas difenil - carboxiaril sustituidas como inhibidores de rafquinasa.

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20140725